VR Logo

Illumina Inc. (ILMN) download report


Healthcare | Diagnostics Services

Illumina Inc. (ILMN) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments.

IPO Date: 28-Jul-2000

CEO & Director: Mr. Francis A. deSouza

CTO & Head of Research and Product Devel.: Dr. Alexander Aravanis M.D., Ph.D.

Listing: NASDAQ: ILMN

Country: United States

Headquarters: San Diego, CA

Website: https://www.illumina.com

Key Facts

Market cap: $35,154.27 Mln

Revenue (TTM): $4,656.00 Mln

Earnings (TTM): $700.00 Mln

Cash: $1,416.00 Mln

Total Debt: $2,615.00 Mln

Insider's Holding: 0.36%

Liquidity: Low

52 Week range: $173.45 - 526.00

Shares outstanding: 157,100,000

10 Years Aggregate:

  • CFO: $7,437.60 Mln
  • EBITDA: $8,855.55 Mln
  • Net Profit: $5,526.21 Mln

Stock Performance

Time Period Illumina (ILMN) S&P BSE Sensex* S&P 100*
YTD-43.451.03-14.21
1 month9.188.635.40
3 months-13.627.330.24
1 Year-56.748.43-7.33
3 Years-10.3417.0613.24
5 Years1.7112.7711.44
10 Years17.3012.8311.31
As on 09-Aug-2022 *As on 08-Aug-2022
Year Illumina (ILMN) S&P 100 S&P BSE Sensex
20212.8227.5521.99
202011.5319.3015.75
201910.6129.4714.38
201837.04-5.825.87
201770.6419.3427.91
2016-33.298.781.95
20153.990.34-5.03